Stay updated with breaking news from Pharma Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) CFO David Kirske sold 60,000 shares of the firm’s stock in a transaction dated Friday, June 17th. The stock was sold at an average price of $6.21, for a total transaction of $372,600.00. Following the completion of the transaction, the chief financial officer now directly owns 7,397 shares […]
CTI BioPharma (NASDAQ:CTIC – Get Rating)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a report released on Monday, TipRanks reports. They presently have a $8.00 target price on the biopharmaceutical company’s stock. Needham & Company LLC’s price target suggests a potential upside of 48.70% from the company’s […]
CTI BioPharma (NASDAQ:CTIC – Get Rating)‘s stock had its “buy” rating reiterated by stock analysts at JMP Securities in a report issued on Monday, TipRanks reports. They presently have a $6.00 target price on the biopharmaceutical company’s stock. JMP Securities’ price objective would indicate a potential upside of 11.52% from the stock’s current price. CTIC […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) CEO Adam R. Craig sold 27,000 shares of the business’s stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $6.00, for a total transaction of $162,000.00. Following the completion of the transaction, the chief executive officer now owns 16,678 shares […]
Nutra Pharma (OTCMKTS:NPHC – Get Rating) and Ayr Wellness (OTCMKTS:AYRWF – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, institutional ownership, earnings and risk. Profitability This table compares Nutra Pharma and Ayr Wellness’ […]